CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 23 enrolled
Drug / intervention
TruSculptdevice
Likely dose
1 TruSculpt radiofrequency treatmentAI-extracted
Key inclusion· 5
  • ✓Age 18-70 years
  • ✓Fitzpatrick skin types I-VI
  • ✓Visible fat bulges, skin laxity, or cellulite in treatment area
  • ✓Non-smoking for at least 6 months and willing to refrain from smoking during study
Key exclusion· 9
  • ✕Pacemaker, internal defibrillator, ICD, nerve stimulator, cochlear implant, or other electronically/magnetically/mechanically activated implant
  • ✕Metal implants locally in or near treatment area (surgical clips, plates, screws, IUD, artificial valves/joints)
  • ✕Significant concurrent illness (diabetes, cardiovascular disease, peripheral vascular disease, or pertinent neurological disorders)
  • ✕Documented immune system disorders

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03018587
NCT03018587N/ACompleted
CompareCT.gov

Feasibility Study of the TruSculpt Radiofrequency Device

Cutera Inc.·interventional·Posted Jan 12, 2017·Updated Mar 7, 2023

In Brief

A clinical study evaluating TruSculpt for Tissue Tightening. Completed, enrolled 23 participants across 1 site.

Detailed Summary

A single-center, prospective, open-label feasibility study of the truSculpt radiofrequency device.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTissue Tightening
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJan 12, 2017
Enrollment StartJan 1, 2017
Primary CompletionDec 1, 2017
Study CompletionDec 29, 2017
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 9.5 years ago

Interventions

TruSculptdevice

All subjects will receive 1 truSculpt radiofrequency treatment